Karnataka minister writes to poll panel seeking EVM challenge

News Network
January 2, 2018

Priyank Kharge, Karnataka Minister for IT and BT, on Tuesday, wrote to the Election Commission of India (ECI), seeking an electronic voting machine (EVM) challenge to test the machines for errors.

In his letter to Achal Kumar Jyoti, the Chief Election Commissioner, Kharge has proposed that the EVM challenge be jointly hosted by the Karnataka government and the ECI, where stakeholders of the scientific community can be invited to participate in testing the EVMs.

Unlike the EVM challenge hosted by the ECI in May 2017, where only political parties participated, Kharge has said that the challenge this time should be thrown open to technocrats, scientists, corporates, R&D institutes, start-ups and tinkerers.

He has sought that the ECI provide 250 randomly selected EVMs to plan and execute the challenge, under the overall supervision of the ECI.

For the challenge, individuals or interested parties can be allowed to test the EVMs using instruments of their choice. Design documents, test descriptions and results, security procedures used by the ECI can be provided for the same. Results obtained can be made public and long-term testing by a team of experts can be initiated, if necessary, he has said.

"The challenge needs to go beyond political parties and should be opened to all the young and bright minds in the country to ensure a pure scientific engagement with the community without political agenda. If there are technical flaws, we can solve it together and if there are no errors, we restore the people's faith in our democratic process," his letter states.

Comments

Wellwisher
 - 
Tuesday, 2 Jan 2018

At Karnataka who wver won that is people selection but to elect election commission must stop EVM system and replace Ballot voting system. Karnataka always support and electing a wisa and qualified Desh Bjakth candidate, So please respect our voting power a d implement Bllot voting system.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 5,2020

Bengaluru, May 5: Karnataka Education Minister, S Suresh Kumar on Monday announced that the SSLC exams will be held as soon as possible, the officials have been asked to be prepared.

The guidelines have been given by the Primary Education Minister to all Deputy Directors of Education departments.

"Sanitisers, masks, screening, and all guidelines will be followed at exam halls," said Kumar in a statement.

Meanwhile, Karnataka has reported 651 COVID-19 positive cases so far, said State Health Department said on Monday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 6,2020

Mangaluru, Apr 6: City Police Commissioner Dr P S Harsha has directed coastal security personnel to block the boat service near Talapady after reports of Kasarogod people using boats to cross over to Dakshina Kannada via Talapady river emerged, Dakshina Kannada District in-charge Minister Kota Srinivas Poojary said here on Monday.

Following the rise in Coronavirus cases in the neighbouring Kasargod district, District Commissioner Sindhu Roopesh ordered closure of borders with Kerala and totally suspended vehicular movement, including for medical emergencies.

However, now the people living in Talapady and surrounding areas allege that the government has failed to monitor people using boats to cross over to Dakshina Kannada via Talapady river.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.